iwan and co-investigators report in this issue of Circulation that the interval between onset of mitral E and annular early diastolic velocity (Ea) by tissue Doppler, T EϪEa , can be used to estimate left ventricular (LV) filling pressure in patients with mitral valve disease. 1 Garcia and colleagues were the first to report that the onset of Ea occurred 7.5Ϯ3.5 ms after peak mitral inflow velocity in 7 patients with restrictive cardiomyopathy, whereas Ea started 22Ϯ19 ms earlier than did E in the normal group. 2 Subsequently, T EϪEa has been shown to correlate with the time constant of LV relaxation () demonstrated by Hasegawa and associates in their elegant animal experiment. 3 With worsening of heart failure by rapid pacing, Ea progressively decreased in velocity and delayed in onset. Mitral E occurred coincidently with the termination of the early diastolic left arterial (LA) and LV pressure gradient at baseline and all stages of heart failure. In contrast, with increasing heart failure, Ea was progressively delayed after LA to LV pressure crossover, and T EϪEa was related to . Rivas-Gotz, Nagueh, and their associates also demonstrated that T EϪEa was prolonged after constriction of the circumflex coronary artery in dogs. 4 In patients with heart failure, LV myocardial relaxation and compliance are decreased.
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Although LV filling is initiated and enhanced by augmentable myocardial relaxation in healthy individuals, it is driven by high filling pressure in patients with heart failure because myocardial relaxation remains reduced, not being sensitive to preload. Myocardial relaxation also affects the isovolumic relaxation time (IVRT). As relaxation becomes abnormal, LV pressure falls more slowly and the opening of the mitral valve is delayed, resulting in a longer IVRT. IVRT, however, becomes shorter as LA pressure increases; hence, IVRTϰ/LA pressure. Because T EϪEa ϰ, IVRTϰT EϪEa /LA pressure or LA pressureϰT EϪEa /IVRT. 1 The same investigators demonstrated that pulmonary capillary wedge pressure (PCWP) is closely related to IVRT/T EϪEa . In fact, IVRT/ T EϪEa Ͻ2 was found to have a sensitivity of 91% and a specificity of 89% for detecting PCWP Ͼ15 mm Hg. 4 Patients with mitral valve disease or atrial fibrillation were not included in the first study, however, and the present report confirmed that both the ratio of IVRT to T EϪEa and to correlate well with PCWP in patients with mitral valve disease or atrial fibrillation. These authors proposed different IVRT/T EϪEa ratio cutoff values for different patient populations to predict PCWP Ͼ15 mm Hg: Ͻ3 for patients with mitral regurgitation, Ͻ4.16 for patients with mitral stenosis, and Ͻ5.59 for patients with mitral regurgitation who were evaluated prospectively or with atrial fibrillation. On repeat studies after the mitral valve procedure, an increase in the ratio by Ն1.5 identified most patients who had a decrease in mean PCWP Ն5 mm Hg.
Tajik and I wrote an editorial 5 for the article by Rivas-Gotz and associates, 4 in which history and clinical applications of various cardiac time intervals were reviewed, and our views on T EϪEa as a surrogate for filling pressure and were expressed. My views for the article by Diwan et al are similar in that the concept of T EϪEa is clever and based on the relationship between myocardial relaxation and LV filling in the healthy and the diseased heart. A potential limitation of applying this ratio clinically is a necessity for measuring cardiac time intervals from 4 different locations and 2 different cardiac cycles. We suggested an approach to record the onset of E and Ea simultaneously, which makes this approach more attractive for clinical use. Another drawback of IVRT/T EϪEa is different cutoff values for different patient populations: 2 for patients with sinus rhythm without mitral valve disease, 3 for patients with mitral regurgitation, 4.16 for patients with mitral stenosis, and 5.59 for patients with atrial fibrillation. It would have been appropriate to provide an explanation for these different cutoff values. Despite these limitations, the findings by Diwan and colleagues clearly define the mechanism of diastolic filling in the healthy and the diseased heart. Their article also provides an opportunity to review the current status of the noninvasive assessment of diastolic filling pressure or PCWP in patients with or without mitral valve disease.
Reliable estimation of filling pressure is the most useful information from the echocardiographic assessment of diastole. Hemodynamically, elevation of filling pressure is a unifying feature for heart failure regardless of underlying cause. Because filling pressure cannot be directly measured noninvasively, we need to use all of the available indirect hemodynamic and functional information to achieve a reliable estimate of filling pressures. Almost always, if not always, patients who have increased filling pressures do have a structural or functional abnormality of the heart. It is unlikely that a patient will have increased filling pressure when cardiac structure and function are normal (ie, normal ejection fraction [EF], normal wall thickness and motion, normal annulus motion, normal LA size, normal pericardium, and no structural abnormalities). Therefore, echocardiographic assessment of filling pressure starts with 2D imaging, The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.
which also provides an explanation when filling pressure is found to be elevated.
Doppler recording of mitral inflow velocities reflecting transmitral pressure relationship is the first step after 2D imaging in echocardiographic assessment of filling pressure. Early diastolic mitral inflow velocity (E) is predominantly determined by myocardial relaxation and left atrial pressure. If LV is dilated and EF is markedly reduced (Ͻ35%), recording mitral inflow velocities alone is often sufficient. 6 Because almost all patients with systolic dysfunction have abnormal myocardial relaxation, mitral inflow velocity pattern demonstrates a characteristic filling pattern if filling pressure is not elevated; early diastolic velocity (E) decreases and deceleration time (DT) of E lengthens (Ͼ240 ms). As filling pressure increases, E increases (E and late diastolic velocity ratio, E/A, is Ͼ1) and DT shortens. Filling pressure is usually increased if DT is Ͻ160 ms. Even in patients with significant mitral regurgitation, DT correlates well with PCWP. 7 Estimation of filling pressure by mitral inflow can be supported by other Doppler parameters such as pulmonary vein velocities and comparison of flow durations, 8 but they may not be necessary in patients with reduced EF; however, in patients with normal EF, it is often difficult to estimate filling pressure by mitral inflow velocity alone.
When EF is normal, the status of myocardial relaxation needs to be assessed by visual assessment, M-mode recording of LV longitudinal motion, or recording of early diastolic velocity (Ea) of the mitral annulus. The normal heart meets a demand of increased LV filling without causing pulmonary venous congestion by augmenting LV suction with improved myocardial relaxation, or increased Ea velocity. 9 If diastolic function is abnormal at rest, however, the heart may not be able to increase LV filling without causing high LA pressure because myocardial relaxation does not improve as well, even with exercise or increased demand for more filling. 2,10 -12 When relaxation is abnormal, not only is its magnitude (Ea) reduced but its onset also is delayed in reference to the onset of mitral valve opening or mitral inflow. From this observation, new indices for increased filling pressure have been identified. As LV filling pressure or PCWP increases, E/Ea ratio rises. When Ea is obtained from the medial mitral annulus, E/Ea Ͼ15 usually indicates PCWP Ͼ20 mm Hg. 13 The ratio should be reduced to Ն10 if the lateral mitral annulus is used. 14 E/Ea was found to correlate better than B-type natriuretic peptide with PCWP 15 and is an easy index to obtain and possible in almost all patients. The correlation of E/Ea with PCWP has been found in patients with atrial fibrillation or sinus tachycardia as well as in sinus rhythm. 16, 17 The ratio was found to correlate well with PCWP in patients with significant functional mitral regurgitation and reduced EF. In patients with primary or organic mitral regurgitation, filling pressures could not be predicted by E/Ea. 18 Therefore, the noninvasive estimation of filling pressure in patients with severe mitral regurgitation and normal EF has been problematic.
T EϪEa is the latest of the echocardiographic parameters to correlate with , and IVRT/T EϪEa appears to have a good correlation with PCWP even in the setting of a mitral valve disease, as reported in this issue of Circulation. Our group measured T EϪEa in 44 patients with acute myocardial infarction and compared the interval with E/Ea. 19 We were able to measure the time intervals in 40 patients, and T EϪEa increased as E/Ea increased. (T EϪEa was 6Ϯ22, 22Ϯ30, and 47Ϯ24 ms for the groups with E/Ea Յ8, between 8 and 15, and Ͼ15, respectively; PϽ0.03.) Sohn and associates, who were the first to demonstrate that Ea was relatively insensitive to preload, 11 could not find a delay in the onset of mitral annulus velocity compared with the onset of mitral inflow over the wide range of (31 to 70 ms), and therefore, no correlation between T EϪEa and 20 (the timing of E and Ea was measured from one location in their study). They also pointed out that the equation IVRT/ T EϪEa could not be applied with a zero denominator when the onset of E and Ea was simultaneous. When T EϪEa was measured at different cardiac cycle lengths between mitral inflow and mitral annulus velocities with simultaneous onset of both velocities at the same cardiac cycle, there was a difference in the onsets in some patients. Therefore, some technical challenges remain in obtaining the cardiac time intervals. Nevertheless, the use of this new parameter, T EϪEa or IVRT/T EϪEa , to assess LV filling pressure, especially when E/Ea cannot be applied, is a great contribution. Further clinical investigation and experience will determine the reliability and role of IVRT/T EϪEa in assessing filling pressure.
Echocardiography has replaced invasive cardiac catheterization for various hemodynamic assessments: cardiac output, valvular pressure gradients, dynamic LV outflow tract gradient, right heart pressures, constrictive pericarditis, and vascular resistance. Of all of the hemodynamic measurements used in daily clinical practice, LV filling pressure is one of the most frequently used. Echocardiography is not able to provide a reliable assessment of diastolic filling pressures under various clinical conditions at patients' bedsides. Diwan and colleagues should be congratulated for their effort to make echocardiography a truly versatile and reliable hemodynamic imaging tool. Thanks to their efforts and those of many other diastology investigators, echocardiography has become a noninvasive Swan-Ganz catheter.
